Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-026662
Filing Date
2024-03-05
Accepted
2024-03-05 20:20:00
Documents
1
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5992
  Complete submission text file 0000950170-24-026662.txt   7553
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address C/O LANTHEUS HOLDINGS, INC. 201 BURLINGTON RD, SOUTH BUILDING BEDFORD MA 01730
Business Address
Provost Jean-Claude (Reporting) CIK: 0001960060 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36569 | Film No.: 24723912